Covid-19
Regional lymphadenopathy following COVID-19 vaccination in patients with or suspicious of breast cancer: a quick summary of current key facts and recommendations.
14 Jun, 2022 | 11:07h | UTCRelated:
2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients
M-A: Respiratory viral co-infections in patients with COVID-19 and associated outcomes.
13 Jun, 2022 | 10:41h | UTC
NIH Updated Guideline: Oxygenation and ventilation for adults with Covid-19.
13 Jun, 2022 | 10:44h | UTCOxygenation and Ventilation for Adults – National Institutes of Health
RCT: Intramuscular tixagevimab–cilgavimab may benefit non-hospitalized unvaccinated adults with Covid-19.
13 Jun, 2022 | 10:39h | UTCCommentaries:
Safety and efficacy of tixagevimab–cilgavimab in preventing severe COVID – News Medical
Commentary on Twitter
NEW—A single intramuscular tixagevimab–cilgavimab dose provided protection against progression to severe COVID-19 or death vs placebo in unvaccinated individuals
TACKLE trial from Prof Hugh Montgomery & colleagues https://t.co/M9LENFsA2C pic.twitter.com/Aon4wJsBOi
— The Lancet Respiratory Medicine (@LancetRespirMed) June 8, 2022
Another study suggests the Omicron variant is associated with a reduced risk of Multisystem Inflammatory Syndrome in Children compared to previous SARS-CoV-2 variants.
10 Jun, 2022 | 12:38h | UTCRelated study: Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel – JAMA AND Commentary: Kids’ COVID syndrome—MIS-C—less severe in Omicron – CIDRAP
Commentary on Twitter
Study found that the risk of multisystem inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection during the #Omicron wave substantially lower compared to previous #SARSCoV2 variants. https://t.co/GYrz9XA72Z
— JAMA Pediatrics (@JAMAPediatrics) June 8, 2022
Cohort Study: Neurodevelopmental outcomes at 1 year in infants of mothers who tested positive for SARS-CoV-2 during pregnancy.
10 Jun, 2022 | 12:14h | UTCCommentaries:
Commentary on Twitter
This cohort study of #SARSCoV2 exposure in utero found preliminary evidence that maternal SARS-CoV-2 may be associated with neurodevelopmental sequelae in some offspring. https://t.co/dYdoJbNOdl
— JAMA Network Open (@JAMANetworkOpen) June 9, 2022
M-A: Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections.
10 Jun, 2022 | 12:00h | UTC
Guidance Statement: Surgical triage and timing for patients with COVID undergoing thoracic surgery.
10 Jun, 2022 | 11:58h | UTC
Review: Pathophysiology and mechanism of long COVID.
10 Jun, 2022 | 11:55h | UTCPathophysiology and mechanism of long COVID: a comprehensive review – Annals of Medicine
[Preprint] Largest study to date on long COVID identifies a broad list of diagnoses.
10 Jun, 2022 | 11:53h | UTCStudy Commentary: Largest study to date on long COVID identifies a broad list of diagnoses – News Medical
Commentary on Twitter
🚨 The arguably largest #LongCovid study to date with millions of participants shows the increased risk of various symptoms after infection and the risk of having to take medications. https://t.co/DSvRcKVKIs pic.twitter.com/uUQxK1VQLv
— Jonas R. Kunst (@kunstjonas.bsky.social) (@KunstJonas) May 23, 2022
Sex differences in clinical characteristics, management strategies, and outcomes of STEMI With COVID-19.
9 Jun, 2022 | 11:24h | UTCEditorial: STEMIs and a Closer Look at MINOCA During the COVID-19 Pandemic – JSCAI
Video: Conversations in Interventional Cardiology: NACMI Registry
Commentary: Mystery MINOCA? Many COVID STEMIs Have No Culprit Lesion – TCTMD
Reducing SARS-CoV-2 in shared indoor air.
8 Jun, 2022 | 11:07h | UTCReducing SARS-CoV-2 in Shared Indoor Air – JAMA
M-A: Efficacy and harms of tocilizumab for the treatment of COVID-19 patients.
8 Jun, 2022 | 11:06h | UTC
M-A: Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19.
8 Jun, 2022 | 11:09h | UTCRelated:
Anticoagulants for people hospitalised with COVID‐19 – Cochrane Library
Commentary on Twitter
🆕💥💥Systematic review & meta-analysis @OFIDJournal Intensified anticoagulation has NO effect on mortality among hospitalised #COVID19 & ⬆️bleeding
Possible signal of mortality reduction for non-ICU patients although with low precision& high heterogeneity https://t.co/OqLYScxK53— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) June 7, 2022
Prospective evaluation of autonomic dysfunction in patients with post-acute sequela of COVID-19.
7 Jun, 2022 | 11:38h | UTCCommentary: Autonomic Dysfunction in Post-Acute Sequela of COVID-19 – American College of Cardiology
Unintended consequences of measures implemented in the school setting to contain the COVID‐19 pandemic: a scoping review.
7 Jun, 2022 | 11:41h | UTCSummary: Unintended consequences of school-based measures to manage the COVID-19 pandemic – Cochrane Library
Prognostic indicators and outcomes of hospitalized COVID-19 patients with neurological disease: An individual patient data meta-analysis.
7 Jun, 2022 | 11:36h | UTC
Special Issue: Covid-19 Infection.
3 Jun, 2022 | 12:04h | UTCHomepage: Covid-19 Infection – Infectious Disease Clinics of North America
Editorial: COVID-19: Where We Are, Where We Need to Be
COVID-19 Pathogenesis and Clinical Manifestations
SARS-CoV-2 Transmission and Prevention in the Era of the Delta Variant
Laboratory Diagnosis for SARS-CoV-2 Infection
Pharmacologic Treatment and Management of Coronavirus Disease 2019
COVID-19 in the Critically Ill Patient
Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus
Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children
Cohort Study: Cardiovascular outcomes in collegiate athletes one year after SARS-CoV-2 Infection.
3 Jun, 2022 | 11:58h | UTC
Commentary on Twitter
Should we worry about athletes who have had covid in the longer term?
Study shows risk of clinically relevant adverse cardiovascular outcomes over 1.2 years of follow-up is low
Surely we would review them regulalry?https://t.co/u3Mz1cFHET pic.twitter.com/5Pt4gbhIKk
— Prof Kamlesh Khunti (@kamleshkhunti) June 2, 2022
Cohort Study: Association of SARS-CoV-2 infection during pregnancy with maternal and perinatal outcomes.
3 Jun, 2022 | 11:55h | UTCAssociation of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes – JAMA
NIH Updated Guideline: Antithrombotic therapy in patients with COVID-19.
2 Jun, 2022 | 11:25h | UTCAntithrombotic Therapy in Patients With COVID-19 – National Institutes of Health
Cohort Study: Diagnostic accuracy of non-invasive detection of SARS-CoV-2 infection by canine olfaction.
2 Jun, 2022 | 11:21h | UTCDiagnostic accuracy of non-invasive detection of SARS-CoV-2 infection by canine olfaction – PLOS One
Commentary on Twitter
The overall sensitivity of Covid detection by trained dogs was 97% and "even reached 100% in asymptomatic individuals" compared to nasopharyngeal swab PCR tests. Overall canine sensitivity vs PCR (97% CI: 91 to 99 versus 84% CI: 74 to 90, p = 0.006), https://t.co/tE2oD6Ecdf pic.twitter.com/uC9hDTH9WM
— Eric Topol (@EricTopol) June 1, 2022
Under a Creative Commons Attribution License license
M-A: Acute and post-acute COVID-19 presentations in athletes.
2 Jun, 2022 | 11:06h | UTC
Video: Care of patients with new, continuing, or recurring symptoms after acute SARS-CoV-2 infection.
2 Jun, 2022 | 11:04h | UTC
Retrospective Cohort Study: Racial and ethnic discrepancy in pulse oximetry and delayed identification of treatment eligibility among patients with COVID-19.
1 Jun, 2022 | 11:58h | UTCEditorial: Racial and Ethnic Bias in Pulse Oximetry and Clinical Outcomes
Related:
Racial Bias in Pulse Oximetry Measurement – New England Journal of Medicine
FDA issues alert on ‘limitations’ of pulse oximeters, without explicit mention of racial bias – STAT
Pulse Oximeter Accuracy and Limitations: FDA Safety Communication – U.S. Food & Drug Administration
Commentary on Twitter
This cohort study found overestimation of arterial oxygen saturation levels by pulse oximetry occurred in Asian, Black, and Hispanic patients with #COVID19 and delayed care compared with White patients. https://t.co/ptOVwuUewr @AshFawzyMD @GoldenSherita @AmandaBradke @BTGaribaldi
— JAMA Internal Medicine (@JAMAInternalMed) May 31, 2022